
What to know about chikungunya virus, as U.S. travel alerts issued
The big picture: At least 240,000 chikungunya cases have been reported in parts of Central and South America, Africa, the Indian Ocean region and Asia this year — with health officials in Guangdong province, South China, confirming 7,000 since June.
What are the symptoms of chikungunya virus?
The painful viral disease is spread to people by infected female mosquitoes that can also transmit dengue and Zika viruses, per the World Health Organization.
"The most common symptoms of chikungunya are fever and joint pain," per the Centers for Disease Control and Prevention.
"Other symptoms can include headache, muscle pain, joint swelling, or rash."
Which countries has the CDC issued travel alerts for?
The CDC has issued level 2 "practice enhanced precautions" chikungunya travel health notices over outbreaks in :
Bolivia, South America.
Guangdong Province, China.
The Indian Ocean region of Madagascar, Mauritius, Mayotte, Réunion, Somalia and Sri Lanka.
Of note: The CDC warns of an elevated risk of exposure for U.S. travelers visiting Brazil, Colombia, India, Mexico, Nigeria, Pakistan, the Philippines and Thailand.
What's happening in China?
Most of the chikungunya illnesses have been reported in Foshan, a Guangdong Province city of about 7.8 million people.
The first case was reported in the financial hub of Hong Kong on Monday.
Officials have launched a " patriotic public health campaign" in response that the New York Times notes is triggering memories of crackdowns during the COVID pandemic.
Zoom in: Foshan crews have been spraying people with insect repellent before letting them in to building entrances, home inspectors have ordered residents to discard stagnant water, per the NYT.
Anyone who doesn't comply may be criminally charged for "obstructing the prevention of infectious diseases," and some Guicheng district households have had their power cut.
Meanwhile, drones have been launched to detect potential mosquito-breeding sites in sources of stagnant water.
Thousands of mosquito-larvae eating fish and cannibal"elephant mosquitoes" that can consume smaller, chikungunya-spreading insects have also been deployed.
Is chikungunya common in the U.S.?
"Locally acquired chikungunya cases have not been reported from U.S. states or territories since 2019," per the CDC.
Yes, but: There were 199 travel-associated reports in the U.S. in 2024 and 46 this year, according to the health agency.
What precautions should U.S. travelers take?
The CDC level 2 alerts advise travelers to affected regions to take enhanced precautions such as using insect repellent, wearing long-sleeved shirts and pants and staying in places with air conditioning or that have screens on the windows and doors.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
14 minutes ago
- Forbes
MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up
Strand Therapeutics founders Jake Becraft (left) and Tasuku Kitada Jon Chomitz As a grad student in biological engineering at MIT, Jake Becraft had an idea that could change the way we treat cancer: What if genes could be turned on and off like light switches? Thinking it through a bit further, he envisioned 'circuits' in which messenger RNA (mRNA), which carries the instructions for making proteins to cells, could be programmed to cause cancerous tumors to reveal themselves to the body's immune system. It was an idea at the cutting-edge of science, and when Becraft cofounded Cambridge, Mass.-based Strand Therapeutics to pursue it there was no guarantee of success. Now, eight years later, Strand seems on the cusp of it. Strand's preliminary phase 1 clinical trial showed that its first programmable mRNA drug is not only safe, but can shrink tumors in cancer patients who had otherwise run out of treatment options. 'It shocked even us,' Becraft told Forbes. 'You hope something happens, but you don't expect to see a huge response because these patients have already proven to have cancers so resistant to treatment.' With those results, Strand Therapeutics raised $153 million in new venture funding led by Swedish investment giant Kinnevik to build out its programmable mRNA therapeutics pipeline. Other investors include VC firms Iconiq and Playground Global; Regeneron Ventures, the venture arm of Regeneron Pharmaceuticals; and drugmakers Amgen and Eli Lilly. The investment brings Strand's total funding to $250 million and its valuation to an estimated $550 million. That number pales in comparison to the stratospheric valuations of today's AI startups, but it's a significant one for a clinical-stage biotech that was worth $359 million at its last round, in November 2024, according to venture-capital database PitchBook. The funding comes at a time when biotech firms have been struggling to raise money and the public markets are filled with zombie biotechs that are trading below their cash on hand. Strand, which hopes to get its first therapy on the market by 2030, does not yet have revenue. Most people know mRNA as the backbone of the vaccines from Moderna and BioNTech during the Covid-19 pandemic. Despite their success, those vaccines have become a political football, with Health & Human Services Secretary Robert F. Kennedy Jr. announcing on Tuesday that he was pulling $500 million of federal funding from mRNA vaccine projects. But mRNA could potentially be used to treat a variety of diseases, from cancer to heart disease. Unlike Covid-19 vaccines, which send instructions to a cell's nucleus to create antigens for a virus, Strand's mRNA therapeutics instruct tumors to produce signals that make them visible to the body's immune system—essentially lighting them up–so that it can fight back. 'The clinical results blew us away,' said Ala Alenazi, an investment manager at Kinnevik, who will join Strand's board of directors with the deal. 'They have been able to prove out these ambitions that had stayed in textbooks.' 'What's become very clear in the past year or year-and-a-half is that the age of messenger RNA and genetic medicines is finally here.' Jake Becraft, cofounder and CEO, Strand Therapeutics Becraft, who is now 34, calls himself 'a reluctant biotech executive.' In 2017, he and Tasuku Kitada, the company's president and head of research and development—the first scientist to create synthetic mRNA gene circuits while working as a researcher at MIT—spun Strand out of MIT. Becraft's Ph.D. advisor, Ron Weiss, a professor of biological engineering whose work focuses on engineering cells and building circuits, was also a cofounder and remains an advisor to the company. In 2019, Strand scored seed funding with Playground leading the round. Its valuation then was just $15.5 million, according to venture-capital database PitchBook. 'They were young Ph.D.s with amazing ideas when we first met with them,' said Jory Bell, a general partner at Playground Global. Becraft has long believed that the biggest barrier to new and personalized medicines is delivery. Today, many therapies are administered by 'brute forcing the proteins into the right cells,' requiring lengthy hospital stays for patients and high costs for insurers, he said. 'What we want to do is deliver proteins that have a therapeutic outcome into a cancer cell or immune cell or into the bone marrow,' he said. That targeting allows the treatment to be potent where it's needed without being toxic where it isn't. 'What's become very clear in the past year or year-and-a-half is that the age of messenger RNA and genetic medicines is finally here,' he said. 'We see that as the path to how we will build medicines in the future.' Consider the first protein that Strand is working with, an immune system stimulant called interleukin 12, or IL-12. It's promising as a cancer immunotherapy, but so far its toxicity has outweighed any anti-cancer benefits. Without targeting, 'it is ineffective or toxic,' Becraft said. 'You want effective and non-toxic.' The results of Strand's study of 22 cancer patients showed it was possible to use targeting to create a potent therapy that wasn't toxic, he said. 'From the very first patients we dosed, we started to see the tumors shrinking,' he said. 'They have been able to prove out these ambitions that had stayed in textbooks.' Ala Alenazi, investment manager, Kinnevik Referring to a contrast dye scan of a patient with stage 4 melanoma, Becraft noted tumors, indicated with black dots, across the body. A second scan of the same patient after treatment with Strand's mRNA drug revealed a stunning improvement. 'The only dot left was where the contrast agent was injected in their arm,' Becraft said. 'I don't think anyone expects that. This was very shocking.' But even with results like this, it's a long road from early clinical trials to commercialization. Strand now plans to use its new influx of funds to conduct additional clinical research with the hopes of getting its first drug approved by 2030. The company also has a few other pre-clinical mRNA therapies in its pipeline, including one that gets infused through a patient's bloodstream rather than injected into a tumor. That would allow it to potentially be used for additional types of cancer that are harder to reach, such as lung cancer. 'We can rewire the way we treat cancer,' Becraft said. 'We think we are just on the precipice of what this technology can do.' MORE FROM FORBES Forbes How A 60-Year-Old Drug Developer Built A $4.4 Billion Biotech Treating 'Butterfly Skin Disease' By Amy Feldman Forbes This AI Founder Became A Billionaire By Building ChatGPT For Doctors By Amy Feldman Forbes How AI And Mini-Organs Could Replace Testing Drugs On Animals By Alex Knapp Forbes Fear Of Super Intelligent AI Is Driving Harvard And MIT Students To Drop Out By Victoria Feng

an hour ago
'Traditionally, it was a Democrat issue': How RFK Jr. is getting left-leaning food laws into deep-red states
Earlier this month, Health and Human Services Secretary Robert F. Kennedy Jr. notched one of his biggest wins of the "Make America Healthy Again" movement when West Virginia became the first state in the country to ban artificial food dyes in school lunches. Since then, a handful of other Republican governors have raced to join in, banning certain food colorings from kids' lunches -- sometimes prohibiting other chemical additives, too. Some GOP leaders have gone further, slapping warning labels on certain food additives statewide. Historically the focus of Democrats, including former first lady Michelle Obama -- and derided as "nanny state" politics by anti-regulation conservatives -- food laws have lately had a windfall of support from the other side of the aisle. Kennedy's "Make America Health Again" crusade against food additives, with its strong backing from President Donald Trump, has taken hold in deeply Republican states such as Louisiana, Texas and Oklahoma. "Traditionally, it was a Democratic issue," Kennedy told ABC News at a press conference on Monday, adding that he is hopeful that Democrats will continue pass food laws in their states despite the "partisan brand" the movement brings. West Virginia -- which has the second-lowest life expectancy rate in the nation, according to the Centers for Disease Control and Prevention -- has taken one of the most stringent approaches, intending to further its ban on artificial dyes and other additives to the whole state by 2028. Its law closely mirrors those passed by California Democrat Gov. Gavin Newsom, who signed similar bills into law before Kennedy and Trump took office. The California Food Safety Act passed in 2023, which banned four additives statewide, and a second California law passed in 2024, which banned six specific synthetic food dyes from school lunches. Both take effect in 2027. "Sometimes you find that there are unorthodox partners, but the key is what you're able to accomplish," West Virginia Gov. Patrick Morrissey, a Republican, told ABC News. If the changes improve health outcomes for West Virginians, it'll be "a win," he said. West Virginia is one of 10 Republican states that have taken steps to regulate food since Kennedy took office. Just two Democratic governors, Arizona Gov. Katie Hobbs and Delaware Gov. Matt Meyer, have signed similar laws in that same timeframe. At the same time, 11 Republican states have applied to the federal government for waivers to prohibit soda or candy from the food benefits program for low-income Americans, SNAP. The sole Democrat-led state to join in on the SNAP policy change is Colorado. More states are waiting in the wings, said John Hewitt, senior vice president of state affairs for the Consumer Brands Association, which represents major food companies such as Kraft Heinz. There's been at least a tenfold increase in the number of food bills introduced or discussed at the state level, he said, and there's been a "substantial shift" in which states are interested. 'Copy and pasting' Democrats' food laws into red states Thomas Galligan, principal scientist for food additives and supplements at the Center for Science in the Public Interest, has worked with states such as California and New York on systemic food reform. And although CSPI has frequently clashed with Kennedy on his policies at HHS, particularly around vaccines, Galligan said on food, "it's fair to give credit where it's due." "I mean, the Trump administration, under RFK Jr., has really elevated this issue on the national stage," he said. But Galligan pushed back on the characterization that it's part of Kennedy's "Make America Health Again" movement, pointing to California's laws, before Kennedy's tenure, as the blueprint. "Most of the bills that we're seeing are really copy and pasting," Galligan said. Six Republican states -- Tennessee, Virginia, Utah, Arizona, Louisiana and Texas -- have passed laws to remove artificial dyes from school lunches, with some states going further and prohibiting additives such as potassium bromate and propylparabens. Texas and Louisiana will also do more -- seeking to warn consumers when they're buying food with additives that are banned in other countries, such as Europe. West Virginia and Arkansas will outright ban certain additives statewide. Some nutritionists and dietitians say that it's best to avoid artificial food dyes, which have been linked in some studies to behavioral changes in children, as well as to cancer in animals, but others say more research needs to be done about the potential negative effects, which are still unclear. Why are food laws different for Republicans this time? For conservatives such as Jeff Singer, a senior fellow at the Cato Institute who studies health policy, the new Republican-led laws around food are a far cry from the days of protesting Obama's "Lets Move!" campaign and former New York City Mayor Michael Bloomberg's attempt to ban Big Gulp soda. "I clearly remember all of the criticism, particularly on right-wing media, of Mayor Bloomberg," Singer said. "All the attacks on Michelle Obama for trying to dictate how people should eat, and dictate what should be in school lunches." "They were basically saying, 'keep your nose out of our private affairs, this is not a role for government, we don't need a nanny state.' But all of a sudden, they're all for a nanny state because it was a very good political move to bring RFK into the MAGA movement," Singer said. The lack of conservative pushback this time around has left the food industry, a powerful lobbying force, as the primary barrier to passing legislation, said Meghan Enslow, policy associate for the Center for Science in the Public Interest. "In all of these states, blue and red, there's been immense lobbying and money spent by the food industry against these bills. And I do wonder if that MAHA narrative is part of what's allowed red states to ignore that money and the voice of the food industry and pass these bills," Enslow said. Kennedy said that a few Democratic governors have told him privately that they intend to get on board. "They don't want to call it MAHA because they think that that's become kind of a partisan brand. I don't care what they call it," Kennedy said. "They want to protect their children. And there's no such thing as Democratic children or Republican children. They're our children, and we should all care about them."
Yahoo
2 hours ago
- Yahoo
Does traveling wreak havoc on your gut? Here's how to avoid an upset stomach
Summer is in full swing, and for many, that means it's time to hit the road. Whether you're on a quick weekend jaunt or a multi-week tour of Europe, there are some things to consider: did you pack sunscreen? A phone charger? And how are you going to take care of your stomach? 'Patients have troubles with stomach issues when they travel because they are exposed to unfamiliar food and water sources, differences in local hygiene and sanitation and changes in routine,' says Dr Franjo Vladic, a gastroenterologist at the Cleveland Clinic. Many of these problems arise as the result of travelers 'not taking logical precautions', says Dr Michael Camilleri, gastroenterologist and professor of medicine at the Mayo Clinic. So how do you protect yourself and your gut when you travel? We asked experts. Related: Wait … can you get a hernia from wearing tight pants? What are the most common travel-related gastrointestinal problems? Traveler's diarrhea According to the Centers for Disease Control and Prevention (CDC), the most predictable travel-related illness is travelers' diarrhea, which affects anywhere from '30% to 70% of travelers during a two-week period, depending on the season of travel'. It is most often the result of consuming food or water that is contaminated with bacteria or viruses. It can come on suddenly and last three to five days, according to the health center at Indiana University Bloomington. In addition, people may experience cramps, nausea, vomiting and fever. Constipation Another common digestive ailment when traveling is constipation. This is often the result of changing one's routine, 'particularly diet (including fiber and fluid intake)', as well as 'altered mobility due to the constraints associated with prolonged travel', explains Camilleri. When traveling, one might try to suppress a bowel movement because of inaccessible toilets, but this only exacerbates the issue. Other Other common stomach issues travelers face include changes in bowel habits, gas, bloating and indigestion, says Dr Aditi Stanton, a board-certified gastroenterologist with Gastro Health in Ohio. She adds that travel can also exacerbate underlying conditions like irritable bowel syndrome (IBS). How can you avoid gastrointestinal distress when traveling? Consistency Travel tends to upend regular schedules and habits, which can wreak havoc on the digestive system. Maintaining some dietary routine can help mitigate this. 'When you're on the go, you're likely eating out more, grabbing fast food or eating fewer fruits, veggies and fiber,' says Stanton. Hydrate and aim for well-balanced meals, she says, and 'be mindful of how much alcohol and caffeine you're having'. Plan ahead If you often suffer from stomach upset when you travel, prepare a toolkit beforehand. 'Bring along anything you might need to stick to your usual routine, plus a few 'just in case' items,' Stanton says. In addition to your regular prescriptions, consider fiber supplements, probiotics, anti-reflux medications, anti-diarrheal medication or oral rehydration or electrolyte solutions. Additionally, if you have a chronic gastrointestinal condition like Crohn's, IBS, ulcerative colitis or gastroesophagal reflux disease (Gerd), it's best to check with your doctor before traveling 'to see if any special prep is needed', says Stanton. Watch what you eat Steer clear of food and water that may be contaminated with bacteria or viruses. This may sound obvious, but spotting contaminated food isn't always straightforward. According to Vladic, some of the worst culprits are raw or undercooked meats, seafood, pre-peeled fruits and vegetables, untreated tap water and ice made from untreated water. In order to avoid potentially contaminated food and beverages, Camilleri suggests eating food that is well cooked and hot, avoiding tap water unless advised otherwise by a 'reliable source', not buying food that has been exposed to the environment for hours instead of refrigerated and washing your hands every time you go to the bathroom and before every meal (ideally, you're doing this at home too).